These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

95 related items for PubMed ID: 2865088

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. [Enalapril in the treatment of essential arterial hypertension].
    Pérez-Grovas H, Fernández M, Arriaga J, Herrera-Acosta J.
    Arch Inst Cardiol Mex; 1986; 56(5):379-90. PubMed ID: 3026264
    [Abstract] [Full Text] [Related]

  • 24. Effects of intensified blood-pressure reduction on renal function and albumin excretion in primary hypertension. Addition of felodipine or ramipril to long-term treatment with beta-blockade.
    Siewert-Delle A, Ljungman S, Hartford M, Wikstrand J.
    Am J Hypertens; 1995 Feb; 8(2):113-23. PubMed ID: 7755939
    [Abstract] [Full Text] [Related]

  • 25. Haemodynamic consequences of intrinsic sympathomimetic activity in relation to changes in plasma renin activity and noradrenaline during beta-blocker therapy for hypertension.
    Man in't Veld AJ, Schalekamp MA.
    Postgrad Med J; 1983 Feb; 59 Suppl 3(689):140-58. PubMed ID: 6139800
    [Abstract] [Full Text] [Related]

  • 26. Prizidilol (SKF 92657) in primary hypertension.
    Karlberg BE, Larsson R, Ohman KP.
    Clin Sci (Lond); 1981 Dec; 61 Suppl 7():461s-464s. PubMed ID: 7188585
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Changing the timing of antihypertensive therapy to reduce nocturnal blood pressure in CKD: an 8-week uncontrolled trial.
    Minutolo R, Gabbai FB, Borrelli S, Scigliano R, Trucillo P, Baldanza D, Laurino S, Mascia S, Conte G, De Nicola L.
    Am J Kidney Dis; 2007 Dec; 50(6):908-17. PubMed ID: 18037091
    [Abstract] [Full Text] [Related]

  • 29. Vasodilators in hypertension--a review with special emphasis on the combined use of vasodilators and beta-adrenoceptor blockers.
    Eggertsen R, Hansson L.
    Int J Clin Pharmacol Ther Toxicol; 1985 Aug; 23(8):411-23. PubMed ID: 2864319
    [Abstract] [Full Text] [Related]

  • 30. Antihypertensive activity of a new vasodilator, cadralazine, administered alone or in combination with a beta-blocker.
    Buoninconti R, Motolese M.
    Int J Clin Pharmacol Ther Toxicol; 1985 Nov; 23(11):613-6. PubMed ID: 2867048
    [Abstract] [Full Text] [Related]

  • 31. Determinants of urinary albumin excretion reduction in essential hypertension: A long-term follow-up study.
    Pascual JM, Rodilla E, Miralles A, Gonzalez C, Redon J.
    J Hypertens; 2006 Nov; 24(11):2277-84. PubMed ID: 17053551
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. [Behavior of arterial pressure, hemodynamic parameters, sympathetic nervous system activity and plasma volume during treatment with a vasodilating and beta-blocking drug in essential hypertension patients].
    Fariello R, Alicandri C, Agabiti-Rosei E, Romanelli G, Montini E, Muiesan ML, Minniti P, Castellano M, Beschi M, Boni E, Zaninelli A, Micheli P, Platto L, Leto Di Priolo S, Muiesan G.
    Boll Soc Ital Cardiol; 1981 Nov; 26(11):1871-4. PubMed ID: 6129877
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Nephroprotection by antihypertensive agents.
    Schmieder RE.
    J Cardiovasc Pharmacol; 1994 Nov; 24 Suppl 2():S55-64. PubMed ID: 7898095
    [Abstract] [Full Text] [Related]

  • 37. Pharmacodynamic and pharmacokinetic studies on prizidilol and nipradilol (K-351), antihypertensive drugs with combined vasodilator and beta-adrenoceptor blocking actions, in rabbits.
    Kawashima K, Watanabe TX, Sokabe H.
    Jpn J Pharmacol; 1984 Dec; 36(4):519-26. PubMed ID: 6151998
    [Abstract] [Full Text] [Related]

  • 38. Acute systemic and renal haemodynamic effects and long-term antihypertensive action of cadralazine in patients pretreated with beta-blockers and diuretics.
    Persson B, Granerus G, Wysocki M, Hedner T, Andersson OK.
    Eur J Clin Pharmacol; 1987 Dec; 31(5):513-8. PubMed ID: 2881788
    [Abstract] [Full Text] [Related]

  • 39. Effects of prizidilol (SKF 92657) on blood pressure, haemodynamics, sympathetic nervous system activity and plasma volume in essential hypertension.
    Fariello R, Alicandri CL, Agabiti-Rosei E, Romanelli G, Castellano M, Beschi M, Platto L, Di Priolo SL, Muiesan G.
    Clin Sci (Lond); 1981 Dec; 61 Suppl 7():465s-468s. PubMed ID: 7318352
    [Abstract] [Full Text] [Related]

  • 40. [Antihypertensive pharmacotherapy with the vasodilators captopril and endralazine].
    Hartmann HG, Schumacher H.
    Schweiz Med Wochenschr; 1985 Jul 09; 115(27-28):939-44. PubMed ID: 2862703
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.